Sale is live|00:00:00left today

Last analyzed: May 28, 2026 (Q2 FY26)

Novo Nordisk A/S

NVO

Pharmaceuticals

$45.51

Market Cap

$203M

P/E Ratio

10.373239

Revenue Rank

Rank 4

Margin Rank

Rank 4

Performance Parameter: Indicating Future Growth(Based on Quarterly Earnings Call)

Explore More Tools

Discover more ways to research and analyze Indian stocks

Stock RankingsAI-ranked stocks from earnings calls Stock ScreenerFilter by P/E, ROE, growth & more IPO DashboardUpcoming, open & listed IPOs Compare StocksSide-by-side stock comparison CalculatorsSIP, CAGR, EMI & more Earnings CalendarUpcoming earnings calls Analyze PortfolioAI health check for your portfolio BlogMarket insights & guides